Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population. (Q53287077)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 January 2011

edit

Language	Label	Description	Also known as
English	Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.	scientific article published on 12 January 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

title

Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

author name string

Pengfei Shao

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Qi Ding

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Chao Qin

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Meilin Wang

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Jialin Tang

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Jian Zhu

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Jiawei Chen

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Qiang Cao

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Jie Li

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Bin Xu

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Zhengdong Zhang

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Wei Zhang

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

Changjun Yin

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

publication date

12 January 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

published in

The Prostate

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

volume

71

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

page(s)

1122-1130

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

cites work

Cancer statistics, 2009

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Human prostate cancer risk factors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Apoptosis in the pathogenesis and treatment of disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Apoptosis in cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

The Fas signalling pathway and its role in the pathogenesis of cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Defining CD95 as a tumor suppressor gene

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

A New Statistical Method for Haplotype Reconstruction from Population Data

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

A comparison of bayesian methods for haplotype reconstruction from population genotype data

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: higher concentrations in angioimmunoblastic T-cell lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Prognostic significance of soluble Fas in the serum of patients with bladder cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Association between FAS polymorphism and prostate cancer development

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FPROS.21328

retrieved

21 January 2018

Identifiers

DOI

10.1002/PROS.21328

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

PubMed publication ID

21557277

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21557277

retrieved

13 May 2018

reference URL

http://europepmc.org/abstract/MED/21557277

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53287077&oldid=1233020036"